Pharma
Pharma M&A deals decline in 2017 amid challenging business climate
18 Oct 2017
“There is interest from Indian companies to acquire assets overseas, across generic and specialty segment. Most players can be seen to bid for available assets though they are looking for the right fit in terms of product portfolio and geography,”
Vrinda Mathur
Partner, Grant Thornton India LLP
This article appeared in Live Mint on 18th October, 2017.
Also appears under...